2124 related articles for article (PubMed ID: 23726093)
21. Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC).
Wada H; Nobori T; Watanabe R; Shiku H; Sakuragawa N
Turk J Haematol; 2002 Jun; 19(2):235-7. PubMed ID: 27264764
[TBL] [Abstract][Full Text] [Related]
22. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.
Gando S; Nakanishi Y; Kameue T; Nanzaki S
J Trauma; 1995 Oct; 39(4):660-4. PubMed ID: 7473950
[TBL] [Abstract][Full Text] [Related]
23. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
24. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
25. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
26. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.
Hoshino M; Haraguchi Y; Hirasawa H; Sakai M; Saegusa H; Hayashi K; Horita N; Ohsawa H
Crit Care; 2001; 5(2):88-99. PubMed ID: 11299067
[TBL] [Abstract][Full Text] [Related]
27. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma.
Gando S; Kameue T; Matsuda N; Hayakawa M; Ishitani T; Morimoto Y; Kemmotsu O
Thromb Haemost; 2002 Dec; 88(6):943-9. PubMed ID: 12529743
[TBL] [Abstract][Full Text] [Related]
28. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
29. Disseminated intravascular coagulation in trauma patients.
Gando S
Semin Thromb Hemost; 2001 Dec; 27(6):585-92. PubMed ID: 11740682
[TBL] [Abstract][Full Text] [Related]
30. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
Fukao H; Yamamoto K; Matsuo O
Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
[TBL] [Abstract][Full Text] [Related]
31. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
[TBL] [Abstract][Full Text] [Related]
32. Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Tanaka H; Nagahama Y; Dokai M; Kashiwakura Y; Ishiwata A; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Thromb Res; 2011 Apr; 127(4):349-55. PubMed ID: 21236472
[TBL] [Abstract][Full Text] [Related]
33. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Nishihira J
Inflammation; 2007 Aug; 30(3-4):118-24. PubMed ID: 17534704
[TBL] [Abstract][Full Text] [Related]
34. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
35. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
36. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
38. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis.
Gando S; Nanzaki S; Kemmotsu O
Ann Surg; 1999 Jan; 229(1):121-7. PubMed ID: 9923809
[TBL] [Abstract][Full Text] [Related]
39. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
40. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
Van Thiel DH; George M; Fareed J
Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
